MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1179)	3/27/1999 6:49:00 AM
From: sim1	Read Replies (1) of 1826

<< just a tad over-enthusiastic about cox-2 inhibitors>> Clueless. I ran across these recently reported Cox-2 (Celebrex) numbers. My sense is that this is being regarded by the cognescente as a fairly "big deal". "..for the week ending March 19, total Celebrex prescriptions dispensed in the U.S. reached 299,571, up 7.3 percent from the previous week. ..In the ten weeks since its introduction in the U.S., a total of 1.5 million Celebrex prescriptions have been dispensed. The majority of weekly Celebrex prescriptions continues to be new prescriptions, which represented 82 percent of prescribing for the week ending March 19. The remaining 18 percent, or 53,620 Celebrex prescriptions, were refills."... imshealth.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next